Skip to main content

How AbbVie made $114B by gaming the US patent system

By The New York Times  
   January 28, 2023

AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.

Full story

Get the latest on healthcare leadership in your inbox.